Working… Menu

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01848327
Recruitment Status : Completed
First Posted : May 7, 2013
Last Update Posted : January 25, 2018
National Multiple Sclerosis Society
Information provided by (Responsible Party):
Leticia Tornes, University of Miami

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017